---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-23-000008"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2023-01-25T23:59:59+00:00"
generated_at: "2026-06-20T10:17:47.612771+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences raises adj EPS guidance for Q4 and FY2022 above prior expectations

## Summary
- Q4 2022 adjusted EPS expected $0.92-$0.96 vs $0.84 in Q4 2021; above Oct guidance high end.
- FY 2022 adjusted EPS expected $3.34-$3.38 vs $3.18 in FY 2021; above Oct guidance high end.
- Preliminary, unaudited results; full Q4 & FY 2022 earnings due Feb 22, 2023.

## SEC filing metadata
- accession: 0000917520-23-000008
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2023-01-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/iart-20230125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-23-000008
- JSON: https://secwatch.observer/filing/0000917520-23-000008.json
- Plain text: https://secwatch.observer/filing/0000917520-23-000008.txt

## Key facts
- Earnings Releases
  INTEGRA LIFESCIENCES HOLDINGS CORP reported fourth quarter 2022 results: EPS $0.92 to $0.96. Guidance raised.
  - Period: fourth quarter 2022
  - EPS: $0.92 to $0.96
  - Guidance: raised
  - Result: preliminary results
  source text: Fourth quarter 2022 adjusted earnings per diluted share is expected to be in a range of $0.92 to $0.96 compared to $0.84 in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm
- Earnings Releases
  INTEGRA LIFESCIENCES HOLDINGS CORP reported full-year 2022 results: EPS $3.34 to $3.38. Guidance raised.
  - Period: full-year 2022
  - EPS: $3.34 to $3.38
  - Guidance: raised
  - Result: preliminary results
  source text: Full-year 2022 adjusted earnings per diluted share is expected to be in a range of $3.34 to $3.38 compared to $3.18 in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.